Evidence map›Paper›PMID 38543042›Full record

ArticleMolecules (Basel, Switzerland)2024

Design, Synthesis, and Biological Evaluation of Novel Coumarin Analogs Targeted against SARS-CoV-2.

Kirti Sharma, Manjinder Singh, Pratibha Sharma, Sumesh C Sharma, Somdutt Mujwar, Mohit Kapoor, Krishna Kumar Mishra, Tanveer A Wani

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kirti SharmaChitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.
Manjinder SinghChitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.ORCID 0000-0001-5477-9222
Pratibha SharmaChitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Sumesh C SharmaChitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.
Somdutt MujwarChitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.ORCID 0000-0003-4037-5475
Mohit KapoorChitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.ORCID 0000-0003-4138-3733
Krishna Kumar MishraChitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.
Tanveer A WaniDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0009-0008-3498-4112
Chitkara University · INKing Saud University · SA

Funding

King Saud University RSP2024R357
6 · The paper itself

Abstract

SARS-CoV, an RNA virus, is contagious and displays a remarkable degree of adaptability, resulting in intricate disease presentations marked by frequent genetic mutations that can ultimately give rise to drug resistance. Targeting its viral replication cycle could be a potential therapeutic option to counter its viral growth in the human body leading to the severe infectious stage. The M

Indexed as

COVID-19SARS-CoV-2Antiviral AgentsBiological AssayCoumarinsHumansKetonesMolecular Docking SimulationMolecular Dynamics SimulationProtease InhibitorsAntiviral AgentsCoumarinsKetonesProtease Inhibitorsmolecular dockingMPronsP3SARS-CoV-2scaffold morphing

Identifiers

PMID38543042
PMCPMC10976223
OpenAlexW4393039650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.